Larvol Delta - SAHARA-Phase-3-Study-of-Intravitreal-OLN324-in-Adults-With-Neovascular-Wet-Agerelated-Macular-Degeneration-nAMD-OLN324CP05

IBI-324 - Innovent Biologics, Ollin Biosciences

Lucentis (ranibizumab) - Roche, Novartis

http://clinicaltrials.gov/ct2/show/NCT07816289

Sep 12, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next